🇺🇸 FDA
Pipeline program

DEXAMETHASONE, DEXAMETHASONE, DEXAMETHASONE

APHP231089

Phase 3 small_molecule active

Quick answer

DEXAMETHASONE, DEXAMETHASONE, DEXAMETHASONE for Multiple Myeloma Multiple myeloma (MM) is a B cell malignancy and is one of the most frequent primary neoplasms of the bone marrow is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Multiple Myeloma Multiple myeloma (MM) is a B cell malignancy and is one of the most frequent primary neoplasms of the bone marrow
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials